This process triggers the recruitment of tyrosine phosphatase I (SHP-1) and other regulatory factors, which in turn modulate and constrain the BCR signaling pathway [167, 174].Variations and polymorphisms in the CD22 gene have been correlated with an increased susceptibility to autoimmune conditions, such as SLE [175]. Here, CD22 is linked to systemic lupus erythematosus.